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Abstract
Purpose:We aimed to study the association between lung function decline and quantitative computed tomography (CT) air
trapping.
Materials and Methods: Current and former heavy smokers in a lung cancer screening trial underwent volumetric low-dose
CT in inspiration and expiration. Spirometry was obtained at baseline and after 3 years. The expiratory to inspiratory ratio of
mean lung density (E/I-ratioMLD) was used to quantify air trapping. CT emphysema was defined as voxels in inspiratory CT
below 2950 Hounsfield Unit. Linear mixed modeling was used to determine the association between CT air trapping and
lung function.
Results: We included 985 subjects with a mean age of 61.3 years. Independent of CT emphysema, CT air trapping was
significantly associated with a reduction in forced expiratory volume in one second (FEV1) and the ratio of FEV1 over the
forced vital capacity (FEV1/FVC); FEV1 declines with 33 mL per percent increase in CT air trapping, while FEV1/FVC declines
0.58% per percent increase (both p,0.001). CT air trapping further elicits accelerated loss of FEV1/FVC (additional 0.24%
reduction per percent increase; p = 0.014).
Conclusion: In a lung cancer screening cohort, quantitatively assessed air trapping on low-dose CT is independently
associated with reduced lung function and accelerated decline of FEV1/FVC.
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Introduction
Chronic obstructive pulmonary disease (COPD) causes chronic
morbidity and mortality, and is expected to be the third leading cause
of death in 2020, with around 8 million deaths annually [1;2]. COPD
is characterized by progressive airflow limitation due to parenchymal
destruction (i.e. emphysema) and/or small airways remodeling, and is
primarily caused by exposure to tobacco smoke [3]. It has been
reported that not all smokers are susceptible to the harmful effects of
tobacco, and only a subgroup has a decline in lung function large
enough to develop COPD [4]. Since smoking cessation is crucial in
managing this disease [5], it would be advantageous to estimate the
rate of decline in heavily smoking subjects without or with early stage
COPD. Given the high expectations of lung cancer screening [6], CT
may gain a role in early identification of such subjects [7].
Both pulmonary emphysema and air trapping can nowadays be
quantified in vivo using computed tomography (CT), but the
relationship between quantitative CT measurements and lung
function decline over time received little attention. It has been
reported that visual [8] and quantitative CT measures of emphysema
[9–11] and hyperinflation [12] are associated with loss of lung function
over time, and may thus be used to identify subjects at a higher risk to
develop COPD. Given that airflow obstruction in COPD starts in the
small airways before the onset of emphysematous destruction [13], air
trapping -which is thought to reflect small airways disease- might show
a strong and more important association with lung function decline in
early stages of the disease, independent of emphysema. However, to
date no studies have investigated the relationship between lung
function decline and expiratory CT data. Therefore, the objective of
this study is to assess the association between lung function decline and
quantitative CT measures of air trapping in a cohort of male heavy
smokers in a lung cancer screening setting.
Materials and Methods
Ethics statement
This study was performed as part of the population-based
Dutch Belgian Lung Cancer Screening Trial (NELSON-trial)
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[14], which was approved by the Dutch Ministry of Health and by
the ethical review board of the University Medical Center Utrecht.
In our center, expiratory CT was added to the screening protocol
in July 2007 to study COPD. This addition was separately
approved by the ethical review board of the University Medical
Center Utrecht. Written informed consent was obtained from each
individual participating in the screening trial.
Study subjects
Participants in the screening trial are current or former heavy
smokers who have smoked at least 16.5 packyears and were phy-
sically fit enough to undergo potential surgery [14]. For this study,
we included all subjects from our center with a lung function test
in the first round of the screening and a paired inspiratory and
expiratory CT, processed for quantitative CT estimates of emphy-
sema and air trapping (N=985). Multiple pulmonary function tests
were available for 442 of these 985 subjects, spanning an obser-
vation time of around three years.
Pulmonary Function Testing
Prebronchodilator spirometry was performed using ZAN equip-
ment (ZANMessgera¨te GmbH, Oberthulba, Germany), according
to American Thoracic Society and European Respiratory Society
guidelines [15]. Spirometry was obtained between 2004 and 2008,
and provided forced expiratory volume in one second (FEV1),
forced vital capacity (FVC) and the FEV1/FCV ratio.
CT scanning and quantitative analysis
All subjects received low-dose volumetric CT in inspiration and
at end-expiration after standardized breathing instructions. CT
imaging was obtained between July 2007 and September 2008.
The images were acquired with 1660.75 mm collimation
(Brilliance 16P; Philips Medical Systems, Cleveland OH, USA).
Settings were adjusted to body weight of the patient: 120 kVp
(#80 kg) or 140 kVp (.80 kg) both at 30 mAs for inspiratory CT,
and 90 kVp (#80 kg) or 120 kVp (.80 kg) both at 20 mAs for
expiratory CT. A scan pair yielded an estimated effective dose of
1.2–2.0 millisievert (mSv), of which 0.3–0.65 mSv is accounted for
by the expiration scan. Images with slice thickness of 1.0 mm at
0.7 mm increment were reconstructed from lung bases to lung
apices using a smooth reconstruction kernel (B-filter; Philips).
The lungs were automatically segmented using dedicated
software [16], and a noise reduction filter was applied to decrease
the influence of noise on the quantitative measurements [17]. The
density of each voxel in the segmented lung volume was assessed
and distributed in an attenuation histogram. From these
histograms the quantitative CT measures were calculated. CT
air trapping was defined as the expiratory to inspiratory ratio of
mean lung density; E/I-ratioMLD [18;19]. CT emphysema was
defined as the percentage of voxels in inspiratory CT with an
attenuation below 2950 Hounsfield Unit (HU); IN2950 [20,21].
Statistical analysis
It has been shown that lung function decline is linear over a
three year period [22]. FEV1 and FEV1/FVC were therefore
analyzed with a random slope, random intercept linear mixed
model. Observation time was chosen as a random parameter,
while all other parameters were fixed. We used an unstructured
covariance matrix. Quantitative CT air trapping, CT emphysema,
age, height, smoking status, packyears smoked and observation
time were inserted into the model. We inserted the interaction
between smoking status and observation time to test for differences
in decline between current- and former smokers. We also inserted
the interactions between CT air trapping and observation time to
test whether differences in decline were dependent on the extent of
CT air trapping.
Observation time and quantitative CT measures are expressed
as median with interquartile range (IQR), all other data are
presented as mean 6 standard deviation (SD). All analyses were
performed with SPSS Version 19.0 for Windows (SPSS, Chicago,
Illinois, USA). A p-value below 0.05 was considered significant.
Results
Study population
The total study population consisted of 985 subjects (99.1%
males) with an age of 61.365.5 years. Current and former smokers
were about equally present. Average FEV1 at baseline was 3.286
0.71 L (96.5618% of predicted value), and average FEV1/FVC
at baseline was 71.669.2%. Study population characteristics are
summarized in Table 1.
Association with lung function
More extensive CT air trapping was significantly associated
with a reduction in FEV1 (p,0.001). For each 1% increase in CT
air trapping the FEV1 is lowered by 33 ml; roughly the annual
Table 1. Characteristics of the study population.
N=985
Male, n (%) 976 (99.1)
Age [year], mean 6 SD 61.365.5
Length [cm], mean 6 SD 17867
Packyears [year], mean 6 SD 40.6617.5
Smoking status
Current smoker, n (%) 528 (53.6)
Former smoker, n (%) 457 (46.4)
FEV1 [L], mean 6 SD 3.2860.71
FEV1 [%predicted], mean 6 SD 96.5618.0
FEV1/FVC [%], mean 6 SD 71.669.2
Airflow obstructiona
No COPD 624 (63.4)
GOLD 1 235 (23.9)
GOLD 2 107 (10.9)
GOLD 3 19 (1.9)
CT Emphysema, IN2950 [%], median (IQR) 0.66 (0.32–1.38)
CT Air trapping, E/I-ratioMLD, median (IQR) 0.84 (0.80–0.88)
Number of PFT
One PFT, n(%) 543 (55.1)
Two PFT, n(%) 369 (37.5)
Three PFT, n(%) 68 (6.9)
Four PFT, n(%) 5 (0.5)
Observation time [year], median (IQR)b 2.9 (2.9–3.0)
aAirflow obstruction defined as FEV1/FVC,0.70, and classified as GOLD 1
(FEV1$80%), GOLD 2 (50%#FEV1,80%) and GOLD 3 (FEV1,50%);
bfollow-up
time in years between multiple visits;
FEV1/FVC ratio of FEV1 over forced vital capacity; FEV1 forced expiratory volume
in the first second; IN2950 percentage of voxels in inspiratory CT with an
attenuation below 2950 Hounsfield Unit; Perc15 15
th percentile of the
attenuation distribution curve; E/I-ratioMLD expiratory to inspiratory ratio of
mean lung density; PFT pulmonary function test.
doi:10.1371/journal.pone.0061783.t001
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decline in healthy male subjects. The estimated effect sizes of the
variables on FEV1 are shown in Table 2.
Increase in height predictably leads to a higher FEV1, while
increases in CT air trapping, CT emphysema, age, packyears
smoked, observation time and being a current smoker all reduce
the FEV1. Moreover, current smokers show an accelerated decline
over time, compared to non-smokers (p = 0.004). CT air trapping
was not significantly associated with an additional accelerated
decline in FEV1. The effect of increase in CT air trapping on
FEV1 is further illustrated in Figure 1.
CT air trapping was also significantly associated with a reduction
in FEV1/FVC (p,0.001). For each 1% increase in CT air trapping
the FEV1/FVC is lowered by 0.58%, roughly three times the
annual decline of 0.18% in healthy male subjects. The estimated
effect sizes of the variables on FEV1/FVC are shown in Table 3.
Increase in CT air trapping, CT emphysema, packyears smoked,
Table 2. Results of linear mixed model analysis–change in lung function parameter per unit change in covariable.
Estimated effects of covariables on FEV1 (mL)
Variable Change FEV1 difference 95%CI p-value
log CT emphysemaa Plus 1 Unit 231.1 253.7–28.53 0.007
CT air trappingb Plus 1% 233.4 239.1–227.7 ,0.001
Smoking status Current smoker 2112.8 2183.7–241.9 0.002
Packyears Plus 1 year 23.9 25.8–21.9 ,0.001
Age in years Plus 1 year 232.9 239.6–226.3 ,0.001
Length in cm Plus 1 cm 38.9 33.7–44.2 ,0.001
Observation time Plus 1 year 256.7 270.0–243.5 ,0.001
Current smoker * Observation time Plus current smoker * 1 year 226.7 244.7–28.7 0.004
aCT emphysema defined as the log transformed percentage of voxels below 2950 Hounsfield Units (IN2950);
bCT air trapping defined as the expiratory to inspiratory
ratio of mean lung density (E/I-ratioMLD); FEV1/FVC ratio of FEV1 over forced vital capacity; FEV1 forced expiratory volume in the first second;
The effect of the covariable on FEV1 can be determined by calculating the product of the coefficient (ie. FEV1 difference) times the increase in covariable (ie. Change).
For example, the maximum loss of FEV1 due to CT emphysema in our population is about 45 mL (ie. log[rangeCT Emphysema]*coefficient) compared to 1276 mL due to CT
air trapping (ie. rangeCT Air trapping*coefficient).
doi:10.1371/journal.pone.0061783.t002
Figure 1. The effect of increase in CT air trapping extent on FEV1. The effect of increasing extent of CT air trapping (25
th percentile, stars; 50th
percentile, squares; 75th percentile, triangles) on FEV1 is shown in a current (left panel) and former smoker (right panel) with fixed values for age/
length/packyears (mean of the study population) and CT emphysema (median of the study population). It is seen that more extensive CT air trapping
leads to a reduction in FEV1.
doi:10.1371/journal.pone.0061783.g001
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observation time and being a current smoker all reduce the FEV1/
FVC. Additionally, CT air trapping not only lowers the FEV1/
FVC, but also elicits an accelerated loss (p= 0.014). Smoking status
was not significantly associated with an accelerated decline in FEV1
/FVC. Our results show that when more extensive air trapping is
present, the steeper this lung function parameter will decline. When
CT air trapping worsens from the 25th percentile (0.80) to the 75th
percentile (0.88) the FEV1/FVC decline increases with an extra
0.24% per year, which is substantial given the normal annual
decline of 0.18%. The effect of increase in CT air trapping on
FEV1/FVC is further illustrated in Figure 2.
Discussion
This study on CT air trapping and lung function decline in
heavily smoking male lung cancer screening participants showed
that more extensive CT air trapping is associated with a substantial
accelerated decline of FEV1/FVC, but not of FEV1. CT air
trapping is further associated with reduced FEV1/FVC and FEV1,
independent from CT emphysema.
No previous studies assessed the association between expiratory
CT measures and lung function over time, and only a few papers
assessed this association for inspiratory CT measures. These studies
mostly found that increasing emphysema was associated with
Table 3. Results of linear mixed model analysis–change in lung function parameter per unit change in covariable.
Estimated effects of covariables on FEV1/FVC (%)
Variable Change FEV1/FVC difference 95%CI p-value
log CT emphysemaa Plus 1 Unit 22.68 23.00–22.36 ,0.001
CT air trappingb Plus 1% 20.58 20.65–20.50 ,0.001
Smoking status Current 21.82 22.70–20.94 ,0.001
Packyears Plus 1 year 20.04 20.06–20.01 0.004
Observation time Plus 1 year +2.50 0.35–4.65 0.02
CT air trapping * Observation time Plus 1% * 1 year 20.03 20.06–20.01 0.01
aCT emphysema defined as the log transformed percentage of voxels below 2950 Hounsfield Units; bCT air trapping defined as the expiratory to inspiratory ratio of
mean lung density; FEV1/FVC ratio of FEV1 over forced vital capacity; FEV1 forced expiratory volume in the first second;
The effect of the covariable on FEV1/FVC can be determined by calculating the product of the coefficient (ie. FEV1/FVC difference) times the increase in covariable (ie.
Change). For example, the maximum loss of FEV1/FVC due to CT emphysema in our population is about 3.9% (ie. log[rangeCT Emphysema]*coefficient) compared to 22.2%
due to CT air trapping (ie. rangeCT Air trapping*coefficient).
doi:10.1371/journal.pone.0061783.t003
Figure 2. The effect of increase in CT air trapping extent on FEV1/FVC. The effect of increasing extent of CT air trapping (25
th percentile, star;
50th percentile, square; 75th percentile, triangle) on FEV1/FVC is shown in a current (left panel) and former smoker (right panel) with fixed values for
age/length/packyears (mean of the study population) and CT emphysema (median of the study population). It is seen that more extensive CT air
trapping leads to a reduction in FEV1/FVC, and the diverging course illustrates the association between CT air trapping and accelerated decline.
doi:10.1371/journal.pone.0061783.g002
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accelerated decline in lung function. Remy-Jardin et al. [8], in a
visual assessment study in 111 volunteers, found that persistent
current smokers with emphysema showed more rapid lung function
decline than subjects without CT abnormalities. This has been
confirmed by several quantitative studies [9–11] in which the extent
of CT emphysema was related to a larger reduction in lung function
over time. Contrarily, Yuan et al. [12] were unable to find an
association between quantitative CT emphysema and lung function
decline in 143 subjects, but they did report a weak association
between hyperinflation on inspiratory CT (defined as the percent-
age of total lung volume that had an inflation value above the
maximal predicted inflation value) and accelerated annual decline
of FEV1.
The present study is compatible to the available literature. Our
observation that CT air trapping, and not CT emphysema, elicits
a steeper FEV1/FVC decline over time is in line with the recent
evidence that COPD starts within the small airways and precedes
emphysematous parenchymal destruction [13]. Also, as the
subjects in the present study had mainly absent or mild
obstruction, our findings are compatible with the idea that small
airways disease leads to air trapping before emphysema develops.
Our findings may thus suggest that small airways dysfunction is
more important than emphysema for lung function decline in early
disease. Nevertheless, it is important to realize that although our
findings are compatible with literature our study does not proof
that small airways disease develops earlier than emphysema. Also,
although presumed, there is no definitive proof that CT air
trapping measures pure small airways disease due to the lack of a
true gold standard.
We further showed the significant relationship between a lower
lung function and both CT emphysema and CT air trapping
extent. However, the contribution of CT emphysema to the lung
function reduction in our study population was limited compared
to the effect of CT air trapping; this is illustrated by the calculated
maximal achievable reduction due to these variables in our
population. Since lung function parameters result from an
expiratory maneuver, a greater effect should indeed be expected
from an expiratory CT measure than from an inspiratory measure
of emphysema extent.
Our study is of importance as it is the first study to report on the
association between expiratory CT data and lung function over
time. The study is strengthened by the fact that all scans were
obtained according to the same protocol, which excludes
interference of scanner differences with the quantitative CT
values. Also, our study population was fairly large and population-
based; it comprised heavily smoking subjects in a screening setting
with mainly absent or mild airflow limitation, instead of severely
affected subjects with end-stage disease. Our study is limited by the
fact that the generalizability to other less exposed populations, to
females subjects and to more severe stages of the disease may be
limited.
In conclusion, we showed that expiratory CT air trapping in
current and former male heavy smokers without or with mild
COPD is independently associated with accelerated decline of
FEV1/FVC and with reduction of FEV1 and FEV1/FVC.
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